Curcumin Modulates 5‐fluorouracil Sensitivity in Colorectal Cancer Cells Through the circ‐NRIP1/miR‐195‐5p/SMURF1/AKT Signaling Axis
Journal of Biochemical and Molecular Toxicology · 2026-03 · 40 (3)
DOI: 10.1002/jbt.70775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 08.03.2026. Verfasst von You Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xi'an Eighth Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Fluorouracil, Colorectal Neoplasms, Curcumin, MicroRNAs. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Henan Province Key Research and Development and Promotion Project, Education Institutions in Henan Province, Project of Scientific and Technological Innovation Guidance in the Healthcare Field of Zhengzhou.
Abstract (Originalsprache)
Curcumin has demonstrated antitumor efficacy, and its therapeutic and adjunct potential is increasingly supported by evidence. However, the anticancer mechanisms of curcumin in combination with chemotherapy remain complex and heterogeneous, warranting further investigation. Although 5‐fluorouracil (5‐FU)‐based chemotherapy remains a cornerstone of colorectal cancer (CRC) management, the emergence of chemoresistance significantly limits its clinical application. Therefore, the present work focused on elucidating the role of curcumin in modulating 5‐FU sensitivity and exploring the underlying molecular mechanism. Initially, we validated the antitumor effects of curcumin both in vivo and in vitro, and demonstrated its synergistic efficacy when combined with 5‐FU. We further identified circ‐NRIP1 as a target of curcumin and confirmed that curcumin enhances 5‐FU sensitivity in CRC cells by downregulating circ‐NRIP1 level. Mechanistic studies revealed that circ‐NRIP1 suppresses SMURF1 expression by competitively binding to miR‐195‐5p, leading to AKT pathway activation, inhibition of apoptosis, and ultimately reduced 5‐FU sensitivity in CRC cells. Collectively, our findings verify that curcumin modulates 5‐FU sensitivity in CRC to through the circ‐NRIP1/miR‐195‐5p/SMURF1/AKT regulatory axis, providing a novel strategic approach for clinical CRC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Xi'an Eighth Hospital, Xi'an, China.
- Department of Clinical Pharmacy, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
- Department of Critical Care Medicine, Shaanxi Provincial Cancer Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, China.
Förderung
- Henan Province Key Research and Development and Promotion Project
- Education Institutions in Henan Province
- Project of Scientific and Technological Innovation Guidance in the Healthcare Field of Zhengzhou
- Henan Provincial Medical Science and Technology Program Project
Zitieren
APA
Chen, Y., Zhang, Y., Zhang, R., Liu, J., & Li, R. (2026). Curcumin Modulates 5‐fluorouracil Sensitivity in Colorectal Cancer Cells Through the circ‐NRIP1/miR‐195‐5p/SMURF1/AKT Signaling Axis. Journal of Biochemical and Molecular Toxicology, 40(3). https://doi.org/10.1002/jbt.70775
Vancouver
Chen Y, Zhang Y, Zhang R, Liu J, Li R. Curcumin Modulates 5‐fluorouracil Sensitivity in Colorectal Cancer Cells Through the circ‐NRIP1/miR‐195‐5p/SMURF1/AKT Signaling Axis. Journal of Biochemical and Molecular Toxicology. 2026;40(3). doi:10.1002/jbt.70775
BibTeX
@article{Chen2026,
author = {Chen, You and Zhang, Yueli and Zhang, Rui and Liu, Jia and Li, Ruijia},
title = {Curcumin Modulates 5‐fluorouracil Sensitivity in Colorectal Cancer Cells Through the circ‐NRIP1/miR‐195‐5p/SMURF1/AKT Signaling Axis},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
volume = {40},
number = {3},
doi = {10.1002/jbt.70775}
}
EUVIMED